Current therapeutic options in pediatric multiple sclerosis.

  title={Current therapeutic options in pediatric multiple sclerosis.},
  author={Eluen Ann Yeh},
  journal={Current treatment options in neurology},
  volume={13 6},
OPINION STATEMENT Therapies for relapsing-remitting pediatric multiple sclerosis (MS) are aimed at preventing relapses (disease modifying therapies), treating acute attacks, and managing disabling cognitive and physical symptoms. Initial disease modifying therapy to prevent relapses should use one of four first-line injectable therapies that are approved for adult relapsing-remitting MS: interferon beta 1a IM, interferon beta 1a SC, interferon beta 1b SC, or glatiramer acetate. If breakthrough… CONTINUE READING